Overview
▼This documentation explains how CSV files from participating sites are processed and mapped to the 'LUCAP Global Hub' REDCap project.
Contents
- CSV File Specifications: The exact column headers, data types, and formatting requirements for each site's import file
- Field Mappings: How source CSV columns map to REDCap fields in the central database
- Data Transformations: Any conversions or processing applied during the import process
- Clinical Quality Indicators (CQI): The relationship between REDCap fields and quality metrics (CQI)
Intended Audience
▼This is written specifically for current or potential LUCAP contributors in technical or detailed-oriented roles.
How to Navigate This Documentation
▼Importers
▼
About Importers: Sites included below have their own CSV import structure and field mappings to the LUCAP REDCap project. Select a site below to view its documentation.
We strongly encourage the adoption of the REDCap column naming for ease of mapping.
QLD Importer
▼Templates
▼
About QLD: This section documents the CSV file structure and field mappings for the QLD site importer.
Download the template below to get the correct column headers, or alternatively upload your CSV file with the COLUMN HEADERS ONLY to validate its structure before importing.
Validate Your CSV
Upload CSV (max 5KB - headers ONLY):
Drop file or click to browse
Max: 5KB
CSV Specification
▼QLD CSV Columns
141 columns✓ Mapped Field
Click to view mapping
○ Unmapped Field
Awaiting mapping
Field Mapping
▼Identifiers Mapping
▼Demographics Mapping
▼Dates Mapping
▼Imaging Mapping
▼
3 targets
3 targets
3 targets
3 targets
3 targets
Bronchoscopy Mapping
▼
3 targets
Biopsy Mapping
▼
3 targets
Diagnosis Mapping
▼
4 targets
4 targets
4 targets
4 targets
Treatment Mapping
▼
2 targets
Mdt Mapping
▼Mortality Mapping
▼SVHS Importer
▼Templates
▼
About SVHS: This section documents the CSV file structure and field mappings for the SVHS site importer.
Download the template below to get the correct column headers, or alternatively upload your CSV file with the COLUMN HEADERS ONLY to validate its structure before importing.
Validate Your CSV
Upload CSV (max 5KB - headers ONLY):
Drop file or click to browse
Max: 5KB
CSV Specification
▼SVHS CSV Columns
175 columns✓ Mapped Field
Click to view mapping
○ Unmapped Field
Awaiting mapping
Field Mapping
▼Identifiers Mapping
▼Demographics Mapping
▼Imaging Mapping
▼Biopsy Mapping
▼Diagnosis Mapping
▼Treatment Mapping
▼Mdt Mapping
▼SWSLHD Importer
▼Templates
▼
About SWSLHD: This section documents the CSV file structure and field mappings for the SWSLHD site importer.
Download the template below to get the correct column headers, or alternatively upload your CSV file with the COLUMN HEADERS ONLY to validate its structure before importing.
Validate Your CSV
Upload CSV (max 5KB - headers ONLY):
Drop file or click to browse
Max: 5KB
CSV Specification
▼SWSLHD CSV Columns
103 columns✓ Mapped Field
Click to view mapping
○ Unmapped Field
Awaiting mapping
Field Mapping
▼Identifiers Mapping
▼Demographics Mapping
▼Dates Mapping
▼Imaging Mapping
▼Bronchoscopy Mapping
▼Biopsy Mapping
▼Diagnosis Mapping
▼Treatment Mapping
▼Mdt Mapping
▼
4 targets
Mortality Mapping
▼
REDCap Data
▼
About REDCap Data: This section documents all fields and lookup values in the LUCAP Global Hub REDCap project.
Data is organized by instrument (form) and includes field definitions and their available options.
REDCap Fields
▼
About REDCap Fields: This section documents all fields in the LUCAP Global Hub REDCap project.
Fields are organized by instrument (form) and include type information based on field naming conventions.
REDCap Columns: CSV of REDCap columns available (153 fields).
Download CSV
System Instrument
▼| REDCap Field Name | Field Type | CQI Numbers |
|---|---|---|
record_id |
Text | — |
source_record_id |
Text | — |
slk_581_code |
Text | — |
facility |
Text | — |
Demographics Instrument
▼Dates Instrument
▼| REDCap Field Name | Field Type | CQI Numbers |
|---|---|---|
cqi_start_date |
Text | |
cqi_start_date_event |
Dropdown | — |
first_specialist_date |
Text | |
first_diag_date |
Text | — |
first_treat_date |
Text | — |
path_conf_date |
Text | — |
days_to_specialist_review |
Calculated | — |
days_to_first_diagnostic |
Calculated | — |
days_to_first_treatment |
Calculated | — |
days_to_diagnosis |
Calculated | — |
Imaging Instrument
▼Bronchoscopy Instrument
▼| REDCap Field Name | Field Type | CQI Numbers |
|---|---|---|
bron_date_1 |
Text | |
bron_type_1 |
Dropdown | |
bron_result_1 |
Dropdown | |
bron_date_2 |
Text | — |
bron_type_2 |
Dropdown | — |
bron_result_2 |
Dropdown | — |
bron_date_3 |
Text | — |
bron_type_3 |
Dropdown | — |
bron_result_3 |
Dropdown | — |
bron_date_4 |
Text | — |
bron_type_4 |
Dropdown | — |
bron_result_4 |
Dropdown | — |
Biopsy Instrument
▼| REDCap Field Name | Field Type | CQI Numbers |
|---|---|---|
biopsy_date_1 |
Text | |
biopsy_procedure_1 |
Dropdown | — |
biopsy_result_1 |
Dropdown | |
biopsy_date_2 |
Text | — |
biopsy_procedure_2 |
Dropdown | — |
biopsy_result_2 |
Dropdown | — |
biopsy_date_3 |
Text | — |
biopsy_procedure_3 |
Dropdown | — |
biopsy_result_3 |
Dropdown | — |
biopsy_date_4 |
Text | — |
biopsy_procedure_4 |
Dropdown | — |
biopsy_result_4 |
Dropdown | — |
Diagnosis Instrument
▼| REDCap Field Name | Field Type | CQI Numbers |
|---|---|---|
diagnosis_date |
Text | |
diagnosis_basis |
Dropdown | |
syn_primary_yn |
Radio | — |
age_at_diagnosis |
Calculated | — |
cancer_group_type |
Dropdown | |
cancer_laterality |
Dropdown | — |
cancer_primary_site_code |
Dropdown | — |
morph_code |
Text | — |
diagnostic_desc3 |
Descriptive | — |
biomarkers_tested |
Checkbox | |
alk_biomarker_date |
Text | — |
alk_status |
Dropdown | |
alk_percent |
Text | — |
egfr_biomarker_date |
Text | — |
egfr_status |
Dropdown | |
egfr_percent |
Text | — |
pdl1_biomarker_date |
Text | — |
pdl1_status |
Dropdown | |
pdl1_percent |
Text | — |
ros1_biomarker_date |
Text | — |
ros1_status |
Dropdown | |
ros1_percent |
Text | — |
Treatment Instrument
▼| REDCap Field Name | Field Type | CQI Numbers |
|---|---|---|
smoke_support_yn |
Radio | — |
treatment_type |
Checkbox | |
rt_intent |
Radio | |
days_diagnosis_to_radio |
Calculated | — |
rt_start_date |
Text | |
rt_stop_date |
Text | — |
rt_type |
Radio | — |
rt_adjuvant |
Radio | — |
rt_prescribed_dose |
Text | — |
rt_prescribed_fractions |
Text | — |
surgery_intent |
Radio | |
surgery_date |
Text | |
days_diagnosis_to_surgery |
Calculated | |
surgery_type |
Radio | — |
surgery_other |
Text | — |
chemo_intent |
Radio | |
chemo_start_date |
Text | |
chemo_stop_date |
Text | — |
days_diagnosis_to_chemo |
Calculated | — |
chemo_adjuvant |
Radio | |
systemic_intent |
Radio | |
systemic_start_date |
Text | |
days_diagnosis_to_systemic |
Calculated | — |
systemic_adjuvant |
Radio | |
systemic_drug_name |
Checkbox | — |
MDT Instrument
▼| REDCap Field Name | Field Type | CQI Numbers |
|---|---|---|
ecog_status |
Dropdown | |
smoke_status |
Radio | |
charlson_idx |
Checkbox | — |
comorbid_count |
Calculated | — |
stage_desc2 |
Descriptive | — |
cdate_of_stage |
Text | |
pdate_of_stage |
Text | — |
c_t_stage |
Dropdown | — |
p_t_stage |
Dropdown | — |
c_n_stage |
Dropdown | — |
p_n_stage |
Dropdown | — |
c_m_stage |
Dropdown | — |
p_m_stage |
Dropdown | — |
c_group |
Dropdown | |
p_group |
Dropdown | |
c_overall |
Dropdown | |
p_overall |
Dropdown | |
c_edition |
Dropdown | — |
p_edition |
Dropdown | — |
lcsn_review_yn |
Radio | |
mdt_treatment_aim |
Radio | |
rfts_date |
Text | |
fev1_predicted |
Text | — |
fev1_measured |
Text | |
fvc_predicted |
Text | — |
fvc_measured |
Text | — |
dlco_predicted |
Text | — |
dlco_measured |
Text | |
kco_predicted |
Text | — |
kco_measured |
Text | — |
mft_meeting_number |
Checkbox | — |
mdt_desc2 |
Descriptive | — |
mdt_date_1 |
Text | |
mdt_date_2 |
Text | — |
mdt_date_3 |
Text | — |
mdt_date_4 |
Text | — |
mdt_date_5 |
Text | — |
mdt_plan_1 |
Checkbox | |
mdt_plan_2 |
Checkbox | — |
mdt_plan_3 |
Checkbox | — |
mdt_plan_4 |
Checkbox | — |
mdt_plan_5 |
Checkbox | — |
mdt_other_1 |
Text | — |
mdt_other_2 |
Text | — |
mdt_other_3 |
Text | — |
mdt_other_4 |
Text | — |
mdt_other_5 |
Text | — |
Mortality Instrument
▼REDCap Lookup Data
▼
About REDCap Lookup Data: This section displays the dropdown, radio button, and checkbox options available for REDCap fields.
Use this reference to understand the valid values and their codes for data entry and validation.
Coverage: 75 fields with 1353 total lookup values across all instruments.
Coverage: 75 fields with 1353 total lookup values across all instruments.
Biopsy Lookups
▼
Lookup Values: This section shows the dropdown, radio button, and checkbox options available for fields in this instrument.
| Code | Label | CQI Numbers |
|---|---|---|
1 |
CT or US guided |
|
2 |
Thoracocentesis |
|
3 |
Pleural biopsy (incl. CT, pleuroscopy, thoracoscopy) |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Positive for malignancy | |
2 |
Negative for malignancy |
|
3 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
CT or US guided |
|
2 |
Thoracocentesis |
|
3 |
Pleural biopsy (incl. CT, pleuroscopy, thoracoscopy) |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Positive for malignancy |
|
2 |
Negative for malignancy |
|
3 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
CT or US guided |
|
2 |
Thoracocentesis |
|
3 |
Pleural biopsy (incl. CT, pleuroscopy, thoracoscopy) |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Positive for malignancy |
|
2 |
Negative for malignancy |
|
3 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
CT or US guided |
|
2 |
Thoracocentesis |
|
3 |
Pleural biopsy (incl. CT, pleuroscopy, thoracoscopy) |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Positive for malignancy |
|
2 |
Negative for malignancy |
|
3 |
Other |
|
Bronchoscopy Lookups
▼
Lookup Values: This section shows the dropdown, radio button, and checkbox options available for fields in this instrument.
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Linear EBUS | |
2 |
Radial EBUS |
|
3 |
Bronchoscopy |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Positive for malignancy | |
2 |
Negative for malignancy |
|
3 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Linear EBUS |
|
2 |
Radial EBUS |
|
3 |
Bronchoscopy |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Positive for malignancy |
|
2 |
Negative for malignancy |
|
3 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Linear EBUS |
|
2 |
Radial EBUS |
|
3 |
Bronchoscopy |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Positive for malignancy |
|
2 |
Negative for malignancy |
|
3 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Linear EBUS |
|
2 |
Radial EBUS |
|
3 |
Bronchoscopy |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Positive for malignancy |
|
2 |
Negative for malignancy |
|
3 |
Other |
|
Dates Lookups
▼
Lookup Values: This section shows the dropdown, radio button, and checkbox options available for fields in this instrument.
| Code | Label | CQI Numbers |
|---|---|---|
1 |
GP Referral |
|
2 |
Internal Hospital Referral |
|
3 |
External Hospital Referral |
|
4 |
Emergency |
|
5 |
Other |
|
Demographics Lookups
▼
Lookup Values: This section shows the dropdown, radio button, and checkbox options available for fields in this instrument.
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Yes |
|
2 |
No |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Male |
|
2 |
Female |
|
3 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Aboriginal but not Torres Strait Islander origin |
|
2 |
Torres Strait Islander but not Aboriginal origin |
|
3 |
Both Aboriginal and Torres Strait Islander origin |
|
4 |
Neither Aboriginal nor Torres Strait Islander origin |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Australia |
|
2 |
England |
|
3 |
India |
|
4 |
China |
|
5 |
New Zealand |
|
6 |
Philippines |
|
7 |
Vietnam |
|
8 |
South Africa |
|
9 |
Malaysia |
|
10 |
Nepal |
|
11 |
Italy |
|
12 |
Sri Lanka |
|
13 |
Indonesia |
|
14 |
United States of America |
|
15 |
Hong Kong |
|
16 |
South Korea |
|
17 |
Germany |
|
18 |
Iraq |
|
19 |
Fiji |
|
20 |
Lebanon |
|
21 |
Pakistan |
|
22 |
Iran |
|
23 |
Thailand |
|
24 |
Scotland |
|
25 |
Myanmar |
|
26 |
Canada |
|
27 |
Singapore |
|
28 |
Greece |
|
29 |
Japan |
|
30 |
Netherlands |
|
31 |
Ireland |
|
32 |
Bangladesh |
|
33 |
Afghanistan |
|
34 |
Cambodia |
|
35 |
Taiwan |
|
36 |
Brazil |
|
37 |
Turkey |
|
38 |
Syria |
|
39 |
France |
|
40 |
Poland |
|
41 |
Ukraine |
|
42 |
Egypt |
|
43 |
Zimbabwe |
|
44 |
Samoa |
|
45 |
Russia |
|
46 |
Chile |
|
47 |
Saudi Arabia |
|
48 |
Israel |
|
49 |
Macedonia |
|
50 |
Somalia |
|
51 |
Hungary |
|
52 |
Albania |
|
53 |
Algeria |
|
54 |
Andorra |
|
55 |
Angola |
|
56 |
Antigua and Barbuda |
|
57 |
Argentina |
|
58 |
Armenia |
|
59 |
Austria |
|
60 |
Azerbaijan |
|
61 |
Bahamas |
|
62 |
Bahrain |
|
63 |
Barbados |
|
64 |
Belarus |
|
65 |
Belgium |
|
66 |
Belize |
|
67 |
Benin |
|
68 |
Bhutan |
|
69 |
Bolivia |
|
70 |
Bosnia and Herzegovina |
|
71 |
Botswana |
|
72 |
Brunei |
|
73 |
Bulgaria |
|
74 |
Burkina Faso |
|
75 |
Burundi |
|
76 |
Cabo Verde |
|
77 |
Cameroon |
|
78 |
Central African Republic |
|
79 |
Chad |
|
80 |
Comoros |
|
81 |
Congo (Congo-Brazzaville) |
|
82 |
Costa Rica |
|
83 |
Côte d’Ivoire |
|
84 |
Croatia |
|
85 |
Cuba |
|
86 |
Cyprus |
|
87 |
Czech Republic |
|
88 |
Djibouti |
|
89 |
Dominica |
|
90 |
Dominican Republic |
|
91 |
Ecuador |
|
92 |
El Salvador |
|
93 |
Equatorial Guinea |
|
94 |
Eritrea |
|
95 |
Estonia |
|
96 |
Eswatini |
|
97 |
Ethiopia |
|
98 |
Gabon |
|
99 |
Gambia |
|
100 |
Georgia |
|
101 |
Ghana |
|
102 |
Grenada |
|
103 |
Guatemala |
|
104 |
Guinea |
|
105 |
Guinea-Bissau |
|
106 |
Guyana |
|
107 |
Haiti |
|
108 |
Honduras |
|
109 |
Iceland |
|
110 |
Jamaica |
|
111 |
Jordan |
|
112 |
Kazakhstan |
|
113 |
Kenya |
|
114 |
Kiribati |
|
115 |
Kuwait |
|
116 |
Kyrgyzstan |
|
117 |
Laos |
|
118 |
Latvia |
|
119 |
Lesotho |
|
120 |
Liberia |
|
121 |
Libya |
|
122 |
Liechtenstein |
|
123 |
Lithuania |
|
124 |
Luxembourg |
|
125 |
Madagascar |
|
126 |
Malawi |
|
127 |
Maldives |
|
128 |
Mali |
|
129 |
Malta |
|
130 |
Marshall Islands |
|
131 |
Mauritania |
|
132 |
Mauritius |
|
133 |
Micronesia |
|
134 |
Moldova |
|
135 |
Monaco |
|
136 |
Mongolia |
|
137 |
Montenegro |
|
138 |
Morocco |
|
139 |
Mozambique |
|
140 |
Namibia |
|
141 |
Nauru |
|
142 |
Nicaragua |
|
143 |
Niger |
|
144 |
Nigeria |
|
145 |
North Korea |
|
146 |
North Macedonia |
|
147 |
Norway |
|
148 |
Oman |
|
149 |
Palau |
|
150 |
Panama |
|
151 |
Papua New Guinea |
|
152 |
Paraguay |
|
153 |
Peru |
|
154 |
Portugal |
|
155 |
Qatar |
|
156 |
Rwanda |
|
157 |
Saint Kitts and Nevis |
|
158 |
Saint Lucia |
|
159 |
Saint Vincent and the Grenadines |
|
160 |
San Marino |
|
161 |
Sao Tome and Principe |
|
162 |
Senegal |
|
163 |
Serbia |
|
164 |
Seychelles |
|
165 |
Sierra Leone |
|
166 |
Slovakia |
|
167 |
Slovenia |
|
168 |
Solomon Islands |
|
169 |
Spain |
|
170 |
Sudan |
|
171 |
Suriname |
|
172 |
Sweden |
|
173 |
Switzerland |
|
174 |
Tajikistan |
|
175 |
Tanzania |
|
176 |
Timor-Leste |
|
177 |
Togo |
|
178 |
Tonga |
|
179 |
Trinidad and Tobago |
|
180 |
Tunisia |
|
181 |
Turkmenistan |
|
182 |
Tuvalu |
|
183 |
Uganda |
|
184 |
United Arab Emirates |
|
185 |
Uruguay |
|
186 |
Uzbekistan |
|
187 |
Vanuatu |
|
188 |
Venezuela |
|
189 |
Yemen |
|
190 |
Zambia, |
|
191 |
Denmark |
|
192 |
Colombia |
|
193 |
Finland |
|
194 |
Wales |
|
195 |
Northern Ireland |
|
196 |
Romania |
|
197 |
United Kingdom, Channel Islands and Isle of Man |
|
198 |
Czechoslovakia |
|
199 |
Cook Islands, |
|
200 |
New Caledonia |
|
999 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
English |
|
2 |
Mandarin |
|
3 |
Arabic |
|
4 |
Vietnamese |
|
5 |
Cantonese |
|
6 |
Punjabi |
|
7 |
Greek |
|
8 |
Italian |
|
9 |
Hindi |
|
10 |
Spanish |
|
11 |
Nepali |
|
12 |
Tagalog |
|
13 |
Korean |
|
14 |
Urdu |
|
15 |
Tamil |
|
16 |
Filipino |
|
17 |
Sinhalese |
|
18 |
Gujarati |
|
19 |
Malayalam |
|
20 |
Indonesian |
|
21 |
Persian (excluding Dari) |
|
22 |
French |
|
23 |
German |
|
24 |
Bengali |
|
25 |
Portuguese |
|
26 |
Turkish |
|
27 |
Japanese |
|
28 |
Serbian |
|
29 |
Samoan |
|
30 |
Russian |
|
31 |
Khmer |
|
32 |
Dari |
|
33 |
Croatian |
|
34 |
Thai |
|
35 |
Macedonian |
|
36 |
Dutch |
|
37 |
Pashto |
|
38 |
Bosnian |
|
39 |
Telugu |
|
40 |
Burmese |
|
41 |
Somali |
|
42 |
Hungarian |
|
43 |
Polish |
|
44 |
Tongan |
|
45 |
Marathi |
|
46 |
Fijian |
|
47 |
Hazaraghi |
|
48 |
Maltese |
|
49 |
Kurdish |
|
50 |
Lao |
|
51 |
Acholi |
|
52 |
Afrikaans |
|
53 |
Akan |
|
54 |
Albanian |
|
55 |
Amharic |
|
56 |
Armenian |
|
57 |
Assamese |
|
58 |
Azerbaijani |
|
59 |
Baluchi |
|
60 |
Bambara |
|
61 |
Basque |
|
62 |
Belarusian |
|
63 |
Bemba |
|
64 |
Breton |
|
65 |
Bulgarian |
|
66 |
Cebuano |
|
67 |
Chichewa |
|
68 |
Corsican |
|
69 |
Cree |
|
70 |
Czech |
|
71 |
Dzongkha |
|
72 |
Ewe |
|
73 |
Faroese |
|
74 |
Finnish |
|
75 |
Georgian |
|
76 |
Hausa |
|
77 |
Hebrew |
|
78 |
Icelandic |
|
79 |
Igbo |
|
80 |
Inuktitut |
|
81 |
Irish |
|
82 |
Javanese |
|
83 |
Kinyarwanda |
|
84 |
Kirundi |
|
85 |
Konkani |
|
86 |
Luxembourgish |
|
87 |
Malagasy |
|
88 |
Maori |
|
89 |
Mongolian |
|
90 |
Nauruan |
|
91 |
Ndebele |
|
92 |
Norwegian |
|
93 |
Oromo |
|
94 |
Quechua |
|
95 |
Romansh |
|
96 |
Scots Gaelic |
|
97 |
Sesotho |
|
98 |
Shona |
|
99 |
Slovak |
|
100 |
Slovenian |
|
101 |
Swahili |
|
102 |
Swedish |
|
103 |
Tatar |
|
104 |
Tswana |
|
105 |
Uzbek |
|
106 |
Wolof |
|
107 |
Xhosa |
|
108 |
Yoruba |
|
109 |
Zulu |
|
110 |
Danish |
|
999 |
Other |
|
Diagnosis Lookups
▼
Lookup Values: This section shows the dropdown, radio button, and checkbox options available for fields in this instrument.
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Histology of Primary Tumour | |
2 |
Histology of Metastasis | |
3 |
Histology (unknown if Primary or Metastasis) | |
4 |
Cytology or Haematology | |
5 |
Specific Tumour Markers (Biochemical or Immunological Testing) |
|
6 |
Exploratory Surgery |
|
7 |
Clinical Investigations |
|
8 |
Clinical Only |
|
9 |
Autopsy with hstology |
|
10 |
Death certificate only |
|
11 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Yes |
|
2 |
No |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Right |
|
2 |
Left |
|
3 |
Bilateral |
|
4 |
Midline |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
C00.0 (Malignant neoplasm of external upper lip) |
|
2 |
C00.1 (Malignant neoplasm of external lower lip) |
|
3 |
C00.2 (Malignant neoplasm of external lip, unspecified) |
|
4 |
C00.3 (Malignant neoplasm of upper lip, inner aspect) |
|
5 |
C00.4 (Malignant neoplasm of lower lip, inner aspect) |
|
6 |
C00.5 (Malignant neoplasm of lip, unspecified, inner aspect) |
|
7 |
C00.6 (Malignant neoplasm of commissure of lip) |
|
8 |
C00.8 (Overlapping malignant lesion of lip) |
|
9 |
C00.9 (Malignant neoplasm of lip, unspecified) |
|
10 |
C01 (Malignant neoplasm of base of tongue) |
|
11 |
C02.0 (Malignant neoplasm of dorsal surface of tongue) |
|
12 |
C02.1 (Malignant neoplasm of border of tongue) |
|
13 |
C02.2 (Malignant neoplasm of ventral surface of tongue) |
|
14 |
C02.3 (Malignant neoplasm of anterior two-thirds of tongue, part unspecified) |
|
15 |
C02.4 (Malignant neoplasm of lingual tonsil) |
|
16 |
C02.8 (Malignant neoplasm of overlapping lesion of tongue) |
|
17 |
C02.9 (Malignant neoplasm of tongue, unspecified) |
|
18 |
C03.0 (Malignant neoplasm of upper gum) |
|
19 |
C03.1 (Malignant neoplasm of lower gum) |
|
20 |
C03.9 (Malignant neoplasm of gum, unspecified) |
|
21 |
C04.0 (Malignant neoplasm of anterior floor of mouth) |
|
22 |
C04.1 (Malignant neoplasm of lateral floor of mouth) |
|
23 |
C04.8 (Overlapping malignant lesion of floor of mouth) |
|
24 |
C04.9 (Malignant neoplasm of floor of mouth, unspecified) |
|
25 |
C05.0 (Malignant neoplasm of hard palate) |
|
26 |
C05.1 (Malignant neoplasm of soft palate) |
|
27 |
C05.2 (Malignant neoplasm of uvula) |
|
28 |
C05.8 (Overlapping malignant lesion of palate) |
|
29 |
C05.9 (Malignant neoplasm of palate, unspecified) |
|
30 |
C06.0 (Malignant neoplasm of cheek mucosa) |
|
31 |
C06.1 (Malignant neoplasm of vestibule of mouth) |
|
32 |
C06.2 (Malignant neoplasm of retromolar area) |
|
33 |
C06.8 (Overlapping malignant lesion of other and unspecified parts of mouth) |
|
34 |
C06.9 (Malignant neoplasm of mouth, unspecified) |
|
35 |
C07 (Malignant neoplasm of parotid gland) |
|
36 |
C08.0 (Malignant neoplasm of submandibular gland) |
|
37 |
C08.1 (Malignant neoplasm of sublingual gland) |
|
38 |
C08.8 (Overlapping malignant lesion of major salivary glands) |
|
39 |
C08.9 (Malignant neoplasm of major salivary gland, unspecified) |
|
40 |
C09.0 (Malignant neoplasm of tonsillar fossa) |
|
41 |
C09.1 (Malignant neoplasm of tonsillar pillar (anterior)(posterior)) |
|
42 |
C09.8 (Overlapping malignant lesion of tonsil) |
|
43 |
C09.9 (Malignant neoplasm of tonsil, unspecified) |
|
44 |
C10.0 (Malignant neoplasm of vallecula) |
|
45 |
C10.1 (Malignant neoplasm of anterior surface of epiglottis) |
|
46 |
C10.2 (Malignant neoplasm of lateral wall of oropharynx) |
|
47 |
C10.3 (Malignant neoplasm of posterior wall of oropharynx) |
|
48 |
C10.4 (Malignant neoplasm of branchial cleft) |
|
49 |
C10.8 (Overlapping malignant lesion of oropharynx) |
|
50 |
C10.9 (Malignant neoplasm of oropharynx, unspecified) |
|
51 |
C11.0 (Malignant neoplasm of superior wall of nasopharynx) |
|
52 |
C11.1 (Malignant neoplasm of posterior wall of nasopharynx) |
|
53 |
C11.2 (Malignant neoplasm of lateral wall of nasopharynx) |
|
54 |
C11.3 (Malignant neoplasm of anterior wall of nasopharynx) |
|
55 |
C11.8 (Overlapping malignant lesion of nasopharynx) |
|
56 |
C11.9 (Malignant neoplasm of nasopharynx, unspecified) |
|
57 |
C12 (Malignant neoplasm of pyriform sinus) |
|
58 |
C13.0 (Malignant neoplasm of postcricoid region) |
|
59 |
C13.1 (Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect) |
|
60 |
C13.2 (Malignant neoplasm of posterior wall of hypopharynx) |
|
61 |
C13.8 (Overlapping malignant lesion of hypopharynx) |
|
62 |
C13.9 (Malignant neoplasm of hypopharynx, unspecified) |
|
63 |
C14.0 (Malignant neoplasm of pharynx, unspecified) |
|
64 |
C14.2 (Malignant neoplasm of Waldeyer ring) |
|
65 |
C14.8 (Overlapping malignant lesion of lip, oral cavity and pharynx) |
|
66 |
C15.0 (Malignant neoplasm of cervical part of oesophagus) |
|
67 |
C15.1 (Malignant neoplasm of thoracic part of oesophagus) |
|
68 |
C15.2 (Malignant neoplasm of abdominal part of oesophagus) |
|
69 |
C15.3 (Malignant neoplasm of upper third of oesophagus) |
|
70 |
C15.4 (Malignant neoplasm of middle third of oesophagus) |
|
71 |
C15.5 (Malignant neoplasm of lower third of oesophagus) |
|
72 |
C15.8 (Overlapping malignant lesion of oesophagus) |
|
73 |
C15.9 (Malignant neoplasm of oesophagus, unspecified) |
|
74 |
C16.0 (Malignant neoplasm of cardia) |
|
75 |
C16.1 (Malignant neoplasm of fundus of stomach) |
|
76 |
C16.2 (Malignant neoplasm of body of stomach) |
|
77 |
C16.3 (Malignant neoplasm of pyloric antrum) |
|
78 |
C16.4 (Malignant neoplasm of pylorus) |
|
79 |
C16.5 (Malignant neoplasm of lesser curvature of stomach, unspecified) |
|
80 |
C16.6 (Malignant neoplasm of greater curvature of stomach, unspecified) |
|
81 |
C16.8 (Overlapping malignant lesion of stomach) |
|
82 |
C16.9 (Malignant neoplasm of stomach, unspecified) |
|
83 |
C17.0 (Malignant neoplasm of duodenum) |
|
84 |
C17.1 (Malignant neoplasm of jejunum) |
|
85 |
C17.2 (Malignant neoplasm of ileum) |
|
86 |
C17.3 (Malignant neoplasm of Meckel's diverticulum) |
|
87 |
C17.8 (Overlapping malignant lesion of small intestine) |
|
88 |
C17.9 (Malignant neoplasm of small intestine, unspecified) |
|
89 |
C18.0 (Malignant neoplasm of caecum) |
|
90 |
C18.1 (Malignant neoplasm of appendix) |
|
91 |
C18.2 (Malignant neoplasm of ascending colon) |
|
92 |
C18.3 (Malignant neoplasm of hepatic flexure) |
|
93 |
C18.4 (Malignant neoplasm of transverse colon) |
|
94 |
C18.5 (Malignant neoplasm of splenic flexure) |
|
95 |
C18.6 (Malignant neoplasm of descending colon) |
|
96 |
C18.7 (Malignant neoplasm of sigmoid colon) |
|
97 |
C18.8 (Overlapping malignant lesion of colon) |
|
98 |
C18.9 (Malignant neoplasm of colon, part unspecified) |
|
99 |
C19 (Malignant neoplasm of rectosigmoid junction) |
|
100 |
C20 (Malignant neoplasm of rectum) |
|
101 |
C21.0 (Malignant neoplasm of anus, unspecified) |
|
102 |
C21.1 (Malignant neoplasm of anal canal) |
|
103 |
C21.2 (Malignant neoplasm of cloacogenic zone) |
|
104 |
C21.8 (Overlapping malignant lesion of rectum, anus and anal canal) |
|
105 |
C22.0 (Liver cell carcinoma) |
|
106 |
C22.1 (Intrahepatic bile duct carcinoma) |
|
107 |
C22.2 (Hepatoblastoma) |
|
108 |
C22.3 (Angiosarcoma of liver) |
|
109 |
C22.4 (Other sarcomas of liver) |
|
110 |
C22.7 (Other specified carcinomas of liver) |
|
111 |
C22.9 (Malignant neoplasm of liver, unspecified) |
|
112 |
C23 (Malignant neoplasm of gallbladder) |
|
113 |
C24.0 (Malignant neoplasm of extrahepatic bile duct) |
|
114 |
C24.1 (Malignant neoplasm of ampulla of Vater) |
|
115 |
C24.8 (Overlapping malignant lesion of biliary tract) |
|
116 |
C24.9 (Malignant neoplasm of biliary tract, unspecified) |
|
117 |
C25.0 (Malignant neoplasm of head of pancreas) |
|
118 |
C25.1 (Malignant neoplasm of body of pancreas) |
|
119 |
C25.2 (Malignant neoplasm of tail of pancreas) |
|
120 |
C25.3 (Malignant neoplasm of pancreatic duct) |
|
121 |
C25.4 (Malignant neoplasm of endocrine pancreas) |
|
122 |
C25.7 (Malignant neoplasm of other parts of pancreas) |
|
123 |
C25.8 (Overlapping malignant lesion of pancreas) |
|
124 |
C25.9 (Malignant neoplasm of pancreas, part unspecified) |
|
125 |
C26.0 (Malignant neoplasm of intestinal tract, part unspecified) |
|
126 |
C26.1 (Malignant neoplasm of spleen) |
|
127 |
C26.8 (Overlapping malignant lesion of digestive system) |
|
128 |
C26.9 (Malignant neoplasm of ill-defined sites within the digestive system) |
|
129 |
C30.0 (Malignant neoplasm of nasal cavity) |
|
130 |
C30.1 (Malignant neoplasm of middle ear) |
|
131 |
C31.0 (Malignant neoplasm of maxillary sinus) |
|
132 |
C31.1 (Malignant neoplasm of ethmoidal sinus) |
|
133 |
C31.2 (Malignant neoplasm of frontal sinus) |
|
134 |
C31.3 (Malignant neoplasm of sphenoidal sinus) |
|
135 |
C31.8 (Overlapping malignant lesion of accessory sinuses) |
|
136 |
C31.9 (Malignant neoplasm of accessory sinus, unspecified) |
|
137 |
C32.0 (Malignant neoplasm of glottis) |
|
138 |
C32.1 (Malignant neoplasm of supraglottis) |
|
139 |
C32.2 (Malignant neoplasm of subglottis) |
|
140 |
C32.3 (Malignant neoplasm of laryngeal cartilage) |
|
141 |
C32.8 (Overlapping malignant lesion of larynx) |
|
142 |
C32.9 (Malignant neoplasm of larynx, unspecified) |
|
143 |
C33 (Malignant neoplasm of trachea) |
|
144 |
C34.0 (Malignant neoplasm of main bronchus) |
|
145 |
C34.1 (Malignant neoplasm of upper lobe, bronchus or lung) |
|
146 |
C34.2 (Malignant neoplasm of middle lobe, bronchus or lung) |
|
147 |
C34.3 (Malignant neoplasm of lower lobe, bronchus or lung) |
|
148 |
C34.8 (Overlapping malignant lesion of bronchus and lung) |
|
149 |
C34.9 (Malignant neoplasm of bronchus or lung, unspecified) |
|
150 |
C37 (Malignant neoplasm of thymus) |
|
151 |
C38.0 (Malignant neoplasm of heart) |
|
152 |
C38.1 (Malignant neoplasm of anterior mediastinum) |
|
153 |
C38.2 (Malignant neoplasm of posterior mediastinum) |
|
154 |
C38.3 (Malignant neoplasm of mediastinum, part unspecified) |
|
155 |
C38.4 (Malignant neoplasm of pleura) |
|
156 |
C38.8 (Overlapping malignant lesion of heart, mediastinum and pleura) |
|
157 |
C39.0 (Malignant neoplasm of upper respiratory tract, part unspecified) |
|
158 |
C39.8 (Overlapping malignant lesion of respiratory and intrathoracic organs) |
|
159 |
C39.9 (Malignant neoplasm of ill-defined sites within the respiratory system) |
|
160 |
C40.0 (Malignant neoplasm of scapula and long bones of upper limb) |
|
161 |
C40.1 (Malignant neoplasm of short bones of upper limb) |
|
162 |
C40.2 (Malignant neoplasm of long bones of lower limb) |
|
163 |
C40.3 (Malignant neoplasm of short bones of lower limb) |
|
164 |
C40.8 (Overlapping malignant lesion of bone and articular cartilage of limbs) |
|
165 |
C40.9 (Malignant neoplasm of bone and articular cartilage of limb, unspecified) |
|
166 |
C41.01 (Malignant neoplasm of craniofacial bones) |
|
167 |
C41.02 (Malignant neoplasm of maxillofacial bones) |
|
168 |
C41.1 (Malignant neoplasm of mandible) |
|
169 |
C41.2 (Malignant neoplasm of vertebral column) |
|
170 |
C41.3 (Malignant neoplasm of ribs, sternum and clavicle) |
|
171 |
C41.4 (Malignant neoplasm of pelvic bones, sacrum and coccyx) |
|
172 |
C41.8 (Overlapping malignant lesion of bone and articular cartilage) |
|
173 |
C41.9 (Malignant neoplasm of bone and articular cartilage, unspecified) |
|
174 |
C43.0 (Malignant melanoma of lip) |
|
175 |
C43.1 (Malignant melanoma of eyelid, including canthus) |
|
176 |
C43.2 (Malignant melanoma of ear and external auricular canal) |
|
177 |
C43.3 (Malignant melanoma of other and unspecified parts of face) |
|
178 |
C43.4 (Malignant melanoma of scalp and neck) |
|
179 |
C43.5 (Malignant melanoma of trunk) |
|
180 |
C43.6 (Malignant melanoma of upper limb, including shoulder) |
|
181 |
C43.7 (Malignant melanoma of lower limb, including hip) |
|
182 |
C43.8 (Overlapping malignant melanoma of skin) |
|
183 |
C43.9 (Malignant melanoma of skin, unspecified) |
|
184 |
C44.0 (Malignant neoplasm of skin of lip) |
|
185 |
C44.1 (Malignant neoplasm of skin of eyelid, including canthus) |
|
186 |
C44.2 (Malignant neoplasm of skin of ear and external auricular canal) |
|
187 |
C44.3 (Malignant neoplasm of skin of other and unspecified parts of face) |
|
188 |
C44.4 (Malignant neoplasm of skin of scalp and neck) |
|
189 |
C44.5 (Malignant neoplasm of skin of trunk) |
|
190 |
C44.6 (Malignant neoplasm of skin of upper limb, including shoulder) |
|
191 |
C44.7 (Malignant neoplasm of skin of lower limb, including hip) |
|
192 |
C44.8 (Overlapping malignant lesion of skin) |
|
193 |
C44.9 (Malignant neoplasm of skin, unspecified) |
|
194 |
C45.0 (Mesothelioma of pleura) |
|
195 |
C45.1 (Mesothelioma of peritoneum) |
|
196 |
C45.2 (Mesothelioma of pericardium) |
|
197 |
C45.7 (Mesothelioma of other sites) |
|
198 |
C45.9 (Mesothelioma, unspecified) |
|
199 |
C46.0 (Kaposi sarcoma of skin) |
|
200 |
C46.1 (Kaposi sarcoma of soft tissue) |
|
201 |
C46.2 (Kaposi sarcoma of palate) |
|
202 |
C46.3 (Kaposi sarcoma of lymph nodes) |
|
203 |
C46.7 (Kaposi sarcoma of other sites) |
|
204 |
C46.8 (Kaposi sarcoma of multiple organs) |
|
205 |
C46.9 (Kaposi sarcoma, unspecified) |
|
206 |
C47.0 (Malignant neoplasm of peripheral nerves of head, face and neck) |
|
207 |
C47.1 (Malignant neoplasm of peripheral nerves of upper limb, including shoulder) |
|
208 |
C47.2 (Malignant neoplasm of peripheral nerves of lower limb, including hip) |
|
209 |
C47.3 (Malignant neoplasm of peripheral nerves of thorax) |
|
210 |
C47.4 (Malignant neoplasm of peripheral nerves of abdomen) |
|
211 |
C47.5 (Malignant neoplasm of peripheral nerves of pelvis) |
|
212 |
C47.6 (Malignant neoplasm of peripheral nerves of trunk, unspecified) |
|
213 |
C47.8 (Overlapping malignant lesion of peripheral nerves and autonomic nervous system) |
|
214 |
C47.9 (Malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified) |
|
215 |
C48.0 (Malignant neoplasm of retroperitoneum) |
|
216 |
C48.1 (Malignant neoplasm of specified parts of peritoneum) |
|
217 |
C48.2 (Malignant neoplasm of peritoneum, unspecified) |
|
218 |
C48.8 (Overlapping malignant lesion of retroperitoneum and peritoneum) |
|
219 |
C49.0 (Malignant neoplasm of connective and soft tissue of head, face and neck) |
|
220 |
C49.1 (Malignant neoplasm of connective and soft tissue of upper limb, including shoulder) |
|
221 |
C49.2 (Malignant neoplasm of connective and soft tissue of lower limb, including hip) |
|
222 |
C49.3 (Malignant neoplasm of connective and soft tissue of thorax) |
|
223 |
C49.4 (Malignant neoplasm of connective and soft tissue of abdomen) |
|
224 |
C49.5 (Malignant neoplasm of connective and soft tissue of pelvis) |
|
225 |
C49.6 (Malignant neoplasm of connective and soft tissue of trunk, unspecified) |
|
226 |
C49.8 (Overlapping malignant lesion of connective and soft tissue) |
|
227 |
C49.9 (Malignant neoplasm of connective and soft tissue, unspecified) |
|
228 |
C50.0 (Malignant neoplasm of nipple and areola) |
|
229 |
C50.1 (Malignant neoplasm of central portion of breast) |
|
230 |
C50.2 (Malignant neoplasm of upper-inner quadrant of breast) |
|
231 |
C50.3 (Malignant neoplasm of lower-inner quadrant of breast) |
|
232 |
C50.4 (Malignant neoplasm of upper-outer quadrant of breast) |
|
233 |
C50.5 (Malignant neoplasm of lower-outer quadrant of breast) |
|
234 |
C50.6 (Malignant neoplasm of axillary tail of breast) |
|
235 |
C50.8 (Overlapping malignant lesion of breast) |
|
236 |
C50.9 (Malignant neoplasm of breast, unspecified part) |
|
237 |
C51.0 (Malignant neoplasm of labium majus) |
|
238 |
C51.1 (Malignant neoplasm of labium minus) |
|
239 |
C51.2 (Malignant neoplasm of clitoris) |
|
240 |
C51.8 (Overlapping malignant lesion of vulva) |
|
241 |
C51.9 (Malignant neoplasm of vulva, unspecified) |
|
242 |
C52 (Malignant neoplasm of vagina) |
|
243 |
C53.0 (Malignant neoplasm of endocervix) |
|
244 |
C53.1 (Malignant neoplasm of exocervix) |
|
245 |
C53.8 (Overlapping malignant lesion of cervix uteri) |
|
246 |
C53.9 (Malignant neoplasm of cervix uteri, unspecified) |
|
247 |
C54.0 (Malignant neoplasm of isthmus uteri) |
|
248 |
C54.1 (Malignant neoplasm of endometrium) |
|
249 |
C54.2 (Malignant neoplasm of myometrium) |
|
250 |
C54.3 (Malignant neoplasm of fundus uteri) |
|
251 |
C54.8 (Overlapping malignant lesion of corpus uteri) |
|
252 |
C54.9 (Malignant neoplasm of corpus uteri, unspecified) |
|
253 |
C55 (Malignant neoplasm of uterus, part unspecified) |
|
254 |
C56 (Malignant neoplasm of ovary) |
|
255 |
C57.0 (Malignant neoplasm of fallopian tube) |
|
256 |
C57.1 (Malignant neoplasm of broad ligament) |
|
257 |
C57.2 (Malignant neoplasm of round ligament) |
|
258 |
C57.3 (Malignant neoplasm of parametrium) |
|
259 |
C57.4 (Malignant neoplasm of uterine adnexa, unspecified) |
|
260 |
C57.7 (Malignant neoplasm of other specified female genital organs) |
|
261 |
C57.8 (Overlapping malignant lesion of female genital organs) |
|
262 |
C57.9 (Malignant neoplasm of female genital organ, unspecified) |
|
263 |
C58 (Malignant neoplasm of placenta) |
|
264 |
C60.0 (Malignant neoplasm of prepuce) |
|
265 |
C60.1 (Malignant neoplasm of glans penis) |
|
266 |
C60.2 (Malignant neoplasm of body of penis) |
|
267 |
C60.8 (Overlapping malignant lesion of penis) |
|
268 |
C60.9 (Malignant neoplasm of penis, unspecified) |
|
269 |
C61 (Malignant neoplasm of prostate) |
|
270 |
C62.0 (Malignant neoplasm of undescended testis) |
|
271 |
C62.1 (Malignant neoplasm of descended testis) |
|
272 |
C62.9 (Malignant neoplasm of testis, unspecified) |
|
273 |
C63.0 (Malignant neoplasm of epididymis) |
|
274 |
C63.1 (Malignant neoplasm of spermatic cord) |
|
275 |
C63.2 (Malignant neoplasm of scrotum) |
|
276 |
C63.7 (Other specified male genital organs) |
|
277 |
C63.8 (Overlapping malignant lesion of male genital organs) |
|
278 |
C63.9 (Malignant neoplasm of male genital organ, unspecified) |
|
279 |
C64 (Malignant neoplasm of kidney, except renal pelvis) |
|
280 |
C65 (Malignant neoplasm of renal pelvis) |
|
281 |
C66 (Malignant neoplasm of ureter) |
|
282 |
C67.0 (Malignant neoplasm of trigone of bladder) |
|
283 |
C67.1 (Malignant neoplasm of dome of bladder) |
|
284 |
C67.2 (Malignant neoplasm of lateral wall of bladder) |
|
285 |
C67.3 (Malignant neoplasm of anterior wall of bladder) |
|
286 |
C67.4 (Malignant neoplasm of posterior wall of bladder) |
|
287 |
C67.5 (Malignant neoplasm of bladder neck) |
|
288 |
C67.6 (Malignant neoplasm of ureteric orifice) |
|
289 |
C67.7 (Malignant neoplasm of urachus) |
|
290 |
C67.8 (Overlapping malignant lesion of bladder) |
|
291 |
C67.9 (Malignant neoplasm of bladder, unspecified) |
|
292 |
C68.0 (Malignant neoplasm of urethra) |
|
293 |
C68.1 (Malignant neoplasm of paraurethral gland) |
|
294 |
C68.8 (Overlapping malignant lesion of urinary organs) |
|
295 |
C68.9 (Malignant neoplasm of urinary organ, unspecified) |
|
296 |
C69.0 (Malignant neoplasm of conjunctiva) |
|
297 |
C69.1 (Malignant neoplasm of cornea) |
|
298 |
C69.2 (Malignant neoplasm of retina) |
|
299 |
C69.3 (Malignant neoplasm of choroid) |
|
300 |
C69.4 (Malignant neoplasm of ciliary body) |
|
301 |
C69.5 (Malignant neoplasm of lacrimal gland and duct) |
|
302 |
C69.6 (Malignant neoplasm of orbit) |
|
303 |
C69.7 (Malignant neoplasm of other specified parts of eye) |
|
304 |
C69.8 (Overlapping malignant lesion of eye and adnexa) |
|
305 |
C69.9 (Malignant neoplasm of eye, unspecified) |
|
306 |
C70.0 (Malignant neoplasm of cerebral meninges) |
|
307 |
C70.1 (Malignant neoplasm of spinal meninges) |
|
308 |
C70.9 (Malignant neoplasm of meninges, unspecified) |
|
309 |
C71.0 (Malignant neoplasm of cerebrum, except lobes and ventricles) |
|
310 |
C71.1 (Malignant neoplasm of frontal lobe) |
|
311 |
C71.2 (Malignant neoplasm of temporal lobe) |
|
312 |
C71.3 (Malignant neoplasm of parietal lobe) |
|
313 |
C71.4 (Malignant neoplasm of occipital lobe) |
|
314 |
C71.5 (Malignant neoplasm of cerebral ventricle) |
|
315 |
C71.6 (Malignant neoplasm of cerebellum) |
|
316 |
C71.7 (Malignant neoplasm of brain stem) |
|
317 |
C71.8 (Overlapping malignant lesion of brain) |
|
318 |
C71.9 (Malignant neoplasm of brain, unspecified) |
|
319 |
C72.0 (Malignant neoplasm of spinal cord) |
|
320 |
C72.1 (Malignant neoplasm of cauda equina) |
|
321 |
C72.2 (Malignant neoplasm of olfactory nerve) |
|
322 |
C72.3 (Malignant neoplasm of optic nerve) |
|
323 |
C72.4 (Malignant neoplasm of acoustic nerve) |
|
324 |
C72.5 (Malignant neoplasm of other and unspecified cranial nerves) |
|
325 |
C72.8 (Overlapping malignant lesion of brain and other parts of central nervous system) |
|
326 |
C72.9 (Malignant neoplasm of central nervous system, unspecified) |
|
327 |
C73 (Malignant neoplasm of thyroid gland) |
|
328 |
C74.0 (Malignant neoplasm of cortex of adrenal gland) |
|
329 |
C74.1 (Malignant neoplasm of medulla of adrenal gland) |
|
330 |
C74.9 (Malignant neoplasm of adrenal gland, unspecified) |
|
331 |
C75.0 (Malignant neoplasm of parathyroid gland) |
|
332 |
C75.1 (Malignant neoplasm of pituitary gland) |
|
333 |
C75.2 (Malignant neoplasm of craniopharyngeal duct) |
|
334 |
C75.3 (Malignant neoplasm of pineal gland) |
|
335 |
C75.4 (Malignant neoplasm of carotid body) |
|
336 |
C75.5 (Malignant neoplasm of aortic body and other paraganglia) |
|
337 |
C75.8 (Malignant neoplasm of pluriglandular involvement, unspecified) |
|
338 |
C75.9 (Malignant neoplasm of endocrine gland, unspecified) |
|
339 |
C76.0 (Malignant neoplasm of head, face and neck) |
|
340 |
C76.1 (Malignant neoplasm of thorax) |
|
341 |
C76.2 (Malignant neoplasm of abdomen) |
|
342 |
C76.31 (Malignant neoplasm of male pelvic organs) |
|
343 |
C76.32 (Malignant neoplasm of female pelvic organs) |
|
344 |
C76.39 (Malignant neoplasm of pelvic organs, not elsewhere classified) |
|
345 |
C76.4 (Malignant neoplasm of upper limb) |
|
346 |
C76.5 (Malignant neoplasm of lower limb) |
|
347 |
C76.7 (Malignant neoplasm of other ill-defined sites) |
|
348 |
C76.8 (Overlapping malignant lesion of other and ill-defined sites) |
|
349 |
C80.0 (Malignant neoplasm, primary site unknown, so stated) |
|
350 |
C80.9 (Malignant neoplasm, primary site unspecified) |
|
351 |
C81.0 (Nodular lymphocyte predominant Hodgkin lymphoma) |
|
352 |
C81.1 (Nodular sclerosis (classical) Hodgkin lymphoma) |
|
353 |
C81.2 (Mixed cellularity (classical) Hodgkin lymphoma) |
|
354 |
C81.3 (Lymphocyte depleted (classical) Hodgkin lymphoma) |
|
355 |
C81.4 (Lymphocyte-rich (classical) Hodgkin lymphoma) |
|
356 |
C81.7 (Other (classical) Hodgkin lymphoma) |
|
357 |
C81.9 (Hodgkin lymphoma, unspecified) |
|
358 |
C82.0 (Follicular lymphoma grade 1) |
|
359 |
C82.1 (Follicular lymphoma grade 2) |
|
360 |
C82.2 (Follicular lymphoma grade 3, unspecified) |
|
361 |
C82.3 (Follicular lymphoma grade 3a) |
|
362 |
C82.4 (Follicular lymphoma grade 3b) |
|
363 |
C82.5 (Diffuse follicle centre lymphoma) |
|
364 |
C82.6 (Cutaneous follicle centre lymphoma) |
|
365 |
C82.7 (Other types of follicular lymphoma) |
|
366 |
C82.9 (Follicular lymphoma, unspecified) |
|
367 |
C83.0 (Small cell B-cell lymphoma) |
|
368 |
C83.1 (Mantle cell lymphoma) |
|
369 |
C83.2 (Mixed small and large cell (diffuse) non-Hodgkin lymphoma) |
|
370 |
C83.3 (Diffuse large B-cell lymphoma) |
|
371 |
C83.4 (Immunoblastic (diffuse) non-Hodgkin lymphoma) |
|
372 |
C83.5 (Lymphoblastic (diffuse) non-follicular lymphoma) |
|
373 |
C83.6 (Undifferentiated (diffuse) non-Hodgkin lymphoma) |
|
374 |
C83.7 (Burkitt lymphoma) |
|
375 |
C83.8 (Other non-follicular lymphoma) |
|
376 |
C83.9 (Non-follicular (diffuse) lymphoma, unspecified) |
|
377 |
C84.0 (Mycosis fungoides) |
|
378 |
C84.1 (Sezary disease) |
|
379 |
C84.2 (T-zone lymphoma) |
|
380 |
C84.3 (Lymphoepithelioid lymphoma) |
|
381 |
C84.4 (Peripheral T-cell lymphoma, not elsewhere classified) |
|
382 |
C84.5 (Other mature T/NK-cell lymphomas) |
|
383 |
C84.6 (Anaplastic large cell lymphoma, ALK-positive) |
|
384 |
C84.7 (Anaplastic large cell lymphoma, ALK-negative) |
|
385 |
C84.8 (Cutaneous T-cell lymphoma, unspecified) |
|
386 |
C84.9 (Mature T/NK-cell lymphoma, unspecified) |
|
387 |
C85.0 (Lymphosarcoma) |
|
388 |
C85.1 (B-cell lymphoma, unspecified) |
|
389 |
C85.2 (Mediastinal (thymic) large B-cell lymphoma) |
|
390 |
C85.7 (Other specified types of non-Hodgkin lymphoma) |
|
391 |
C85.9 (Non-Hodgkin lymphoma, unspecified) |
|
392 |
C86.0 (Extranodal NK/T-cell lymphoma, nasal type) |
|
393 |
C86.1 (Hepatosplenic T-cell lymphoma) |
|
394 |
C86.2 (Enteropathy-type (intestinal) T-cell lymphoma) |
|
395 |
C86.3 (Subcutaneous panniculitis-like T-cell lymphoma) |
|
396 |
C86.4 (Blastic NK-cell lymphoma) |
|
397 |
C86.5 (Angioimmunoblastic T-cell lymphoma) |
|
398 |
C86.6 (Primary cutaneous CD30-positive T-cell proliferations) |
|
399 |
C88.00 (Waldenstrom macroglobulinaemia, without mention of remission) |
|
400 |
C88.01 (Waldenstrom macroglobulinaemia, in remission) |
|
401 |
C88.10 (Alpha heavy chain disease, without mention of remission) |
|
402 |
C88.11 (Alpha heavy chain disease, in remission) |
|
403 |
C88.20 (Other heavy chain disease, without mention of remission) |
|
404 |
C88.21 (Other heavy chain disease, in remission) |
|
405 |
C88.30 (Immunoproliferative small intestinal disease, without mention of remission) |
|
406 |
C88.31 (Immunoproliferative small intestinal disease, in remission) |
|
407 |
C88.40 (Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma], without mention of remission) |
|
408 |
C88.41 (Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma], in remission) |
|
409 |
C88.70 (Other malignant immunoproliferative diseases, without mention of remission) |
|
410 |
C88.71 (Other malignant immunoproliferative diseases, in remission) |
|
411 |
C88.90 (Malignant immunoproliferative disease, unspecified, without mention of remission) |
|
412 |
C88.91 (Malignant immunoproliferative disease, unspecified, in remission) |
|
413 |
C90.00 (Multiple myeloma, without mention of remission) |
|
414 |
C90.01 (Multiple myeloma, in remission) |
|
415 |
C90.10 (Plasma cell leukaemia, without mention of remission) |
|
416 |
C90.11 (Plasma cell leukaemia, in remission) |
|
417 |
C90.20 (Extramedullary plasmacytoma, without mention of remission) |
|
418 |
C90.21 (Extramedullary plasmacytoma, in remission) |
|
419 |
C90.30 (Solitary plasmacytoma, without mention of remission) |
|
420 |
C90.31 (Solitary plasmacytoma, in remission) |
|
421 |
C91.00 (Acute lymphoblastic leukaemia [ALL], without mention of remission) |
|
422 |
C91.01 (Acute lymphoblastic leukaemia [ALL], in remission) |
|
423 |
C91.10 (Chronic lymphocytic leukaemia of B-cell type, without mention of remission) |
|
424 |
C91.11 (Chronic lymphocytic leukaemia of B-cell type, in remission) |
|
425 |
C91.20 (Subacute lymphocytic leukaemia, without mention of remission) |
|
426 |
C91.21 (Subacute lymphocytic leukaemia, in remission) |
|
427 |
C91.30 (Prolymphocytic leukaemia of B-cell type, without mention of remission) |
|
428 |
C91.31 (Prolymphocytic leukaemia of B-cell type, in remission) |
|
429 |
C91.40 (Hairy-cell leukaemia, without mention of remission) |
|
430 |
C91.41 (Hairy-cell leukaemia, in remission) |
|
431 |
C91.50 (Adult T-cell leukaemia/lymphoma [HTLV-1-associated], without mention of remission) |
|
432 |
C91.51 (Adult T-cell leukaemia/lymphoma [HTLV-1-associated], in remission) |
|
433 |
C91.60 (Prolymphocytic leukaemia of T-cell type, without mention of remission) |
|
434 |
C91.61 (Prolymphocytic leukaemia of T-cell type, in remission) |
|
435 |
C91.70 (Other lymphoid leukaemia, without mention of remission) |
|
436 |
C91.71 (Other lymphoid leukaemia, in remission) |
|
437 |
C91.80 (Mature B-cell leukaemia Burkitt-type, without mention of remission) |
|
438 |
C91.81 (Mature B-cell leukaemia Burkitt-type, in remission) |
|
439 |
C91.90 (Lymphoid leukaemia, unspecified, without mention of remission) |
|
440 |
C91.91 (Lymphoid leukaemia, unspecified, in remission) |
|
441 |
C92.00 (Acute myeloblastic leukaemia [AML], without mention of remission) |
|
442 |
C92.01 (Acute myeloblastic leukaemia [AML], in remission) |
|
443 |
C92.10 (Chronic myeloid leukaemia [CML], BCR/ABL-positive, without mention of remission) |
|
444 |
C92.11 (Chronic myeloid leukaemia [CML], BCR/ABL-positive, in remission) |
|
445 |
C92.20 (Atypical chronic myeloid leukaemia, BCR/ABL-negative, without mention of remission) |
|
446 |
C92.21 (Atypical chronic myeloid leukaemia, BCR/ABL-negative, in remission) |
|
447 |
C92.30 (Myeloid sarcoma, without mention of remission) |
|
448 |
C92.31 (Myeloid sarcoma, in remission, in remission) |
|
449 |
C92.40 (Acute promyelocytic leukaemia [PML], without mention of remission) |
|
450 |
C92.41 (Acute promyelocytic leukaemia [PML], in remission) |
|
451 |
C92.50 (Acute myelomonocytic leukaemia, without mention of remission) |
|
452 |
C92.51 (Acute myelomonocytic leukaemia, in remission) |
|
453 |
C92.60 (Acute myeloid leukaemia with 11q23-abnormality, without mention of remission) |
|
454 |
C92.61 (Acute myeloid leukaemia with 11q23-abnormality, in remission) |
|
455 |
C92.70 (Other myeloid leukaemia, without mention of remission) |
|
456 |
C92.71 (Other myeloid leukaemia, in remission) |
|
457 |
C92.80 (Acute myeloid leukaemia with multilineage dysplasia, without mention of remission) |
|
458 |
C92.81 (Acute myeloid leukaemia with multilineage dysplasia, in remission) |
|
459 |
C92.90 (Myeloid leukaemia, unspecified, without mention of remission) |
|
460 |
C92.91 (Myeloid leukaemia, unspecified, in remission) |
|
461 |
C93.00 (Acute monoblastic/monocytic leukaemia, without mention of remission) |
|
462 |
C93.01 (Acute monoblastic/monocytic leukaemia, in remission) |
|
463 |
C93.10 (Chronic myelomonocytic leukaemia [CMML], without mention of remission) |
|
464 |
C93.11 (Chronic myelomonocytic leukaemia [CMML], in remission) |
|
465 |
C93.20 (Subacute monocytic leukaemia, without mention of remission) |
|
466 |
C93.21 (Subacute monocytic leukaemia, in remission) |
|
467 |
C93.30 (Juvenile myelomonocytic leukaemia, without mention of remission) |
|
468 |
C93.31 (Juvenile myelomonocytic leukaemia, in remission) |
|
469 |
C93.70 (Other monocytic leukaemia, without mention of remission) |
|
470 |
C93.71 (Other monocytic leukaemia, in remission) |
|
471 |
C93.90 (Monocytic leukaemia, unspecified, without mention of remission) |
|
472 |
C93.91 (Monocytic leukaemia, unspecified, in remission) |
|
473 |
C94.00 (Acute erythroid leukaemia, without mention of remission) |
|
474 |
C94.01 (Acute erythroid leukaemia, in remission) |
|
475 |
C94.10 (Chronic erythraemia, without mention of remission) |
|
476 |
C94.11 (Chronic erythraemia, in remission) |
|
477 |
C94.20 (Acute megakaryoblastic leukaemia, without mention of remission) |
|
478 |
C94.21 (Acute megakaryoblastic leukaemia, in remission) |
|
479 |
C94.30 (Mast cell leukaemia, without mention of remission) |
|
480 |
C94.31 (Mast cell leukaemia, in remission) |
|
481 |
C94.40 (Acute panmyelosis with myelofibrosis, without mention of remission) |
|
482 |
C94.41 (Acute panmyelosis with myelofibrosis, in remission) |
|
483 |
C94.50 (Acute myelofibrosis, without mention of remission) |
|
484 |
C94.51 (Acute myelofibrosis, in remission) |
|
485 |
C94.60 (Myelodysplastic and myeloproliferative disease, not elsewhere classified, without mention of remission) |
|
486 |
C94.61 (Myelodysplastic and myeloproliferative disease, not elsewhere classified, in remission) |
|
487 |
C94.70 (Other specified leukaemias, without mention of remission) |
|
488 |
C94.71 (Other specified leukaemias, in remission) |
|
489 |
C95.00 (Acute leukaemia of unspecified cell type, without mention of remission) |
|
490 |
C95.01 (Acute leukaemia of unspecified cell type, in remission) |
|
491 |
C95.10 (Chronic leukaemia of unspecified cell type, without mention of remission) |
|
492 |
C95.11 (Chronic leukaemia of unspecified cell type, in remission) |
|
493 |
C95.20 (Subacute leukaemia of unspecified cell type, without mention of remission) |
|
494 |
C95.21 (Subacute leukaemia of unspecified cell type, in remission) |
|
495 |
C95.70 (Other leukaemia of unspecified cell type, without mention of remission) |
|
496 |
C95.71 (Other leukaemia of unspecified cell type, in remission) |
|
497 |
C95.90 (Leukaemia, unspecified, without mention of remission) |
|
498 |
C95.91 (Leukaemia, unspecified, in remission) |
|
499 |
C96.0 (Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis [Letterer-Siwe disease]) |
|
500 |
C96.1 (Malignant histiocytosis) |
|
501 |
C96.2 (Malignant mast cell tumour) |
|
502 |
C96.3 (True histiocytic lymphoma) |
|
503 |
C96.4 (Sarcoma of dendritic cells (accessory cells)) |
|
504 |
C96.5 (Multifocal and unisystemic Langerhans-cell histiocytosis) |
|
505 |
C96.6 (Unifocal Langerhans-cell histiocytosis) |
|
506 |
C96.7 (Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue) |
|
507 |
C96.8 (Histiocytic sarcoma) |
|
508 |
C96.9 (Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified) |
|
509 |
C97 (Malignant neoplasms of independent (primary) multiple sites) |
|
510 |
D02.2 (Carcinoma in situ of bronchus and lung ) |
|
511 |
D03.0 (Melanoma in situ of lip) |
|
512 |
D03.1 (Melanoma in situ of eyelid, including canthus) |
|
513 |
D03.2 (Melanoma in situ of ear and external auricular canal) |
|
514 |
D03.3 (Melanoma in situ of other and unspecified parts of face) |
|
515 |
D03.4 (Melanoma in situ of scalp and neck) |
|
516 |
D03.5 (Melanoma in situ of trunk) |
|
517 |
D03.6 (Melanoma in situ of upper limb, including shoulder) |
|
518 |
D03.7 (Melanoma in situ of lower limb, including hip) |
|
519 |
D03.8 (Melanoma in situ of other sites) |
|
520 |
D03.9 (Melanoma in situ, unspecified) |
|
521 |
D05.0 (Lobular carcinoma in situ of breast) |
|
522 |
D05.1 (Intraductal carcinoma in situ of breast) |
|
523 |
D05.7 (Other carcinoma in situ of breast) |
|
524 |
D05.9 (Carcinoma in situ of breast, unspecified) |
|
525 |
D09.0 (Carcinoma in situ of bladder ) |
|
526 |
D32.0 (Benign neoplasm of cerebral meninges) |
|
527 |
D32.1 (Benign neoplasm of spinal meninges) |
|
528 |
D32.9 (Benign neoplasm of meninges, unspecified) |
|
529 |
D33.0 (Benign neoplasm of brain, supratentorial) |
|
530 |
D33.1 (Benign neoplasm of brain, infratentorial ) |
|
531 |
D33.2 (Benign neoplasm of brain unspecified ) |
|
532 |
D33.3 (Benign neoplasm of cranial nerves) |
|
533 |
D33.4 (Benign neoplasm of spinal cord ) |
|
534 |
D33.7 (Benign neoplasm of other specified parts of central nervous system ) |
|
535 |
D33.9 (Benign neoplasm of central nervous system, unspecified) |
|
536 |
D35.2 (Benign neoplasm of pituitary gland) |
|
537 |
D35.3 (Benign neoplasm of craniopharyngeal duct ) |
|
538 |
D35.4 (Benign neoplasm of pineal gland) |
|
539 |
D42.0 (Neoplasm of uncertain or unknown behaviour of cerebral meninges ) |
|
540 |
D42.1 (Neoplasm of uncertain or unknown behaviour of spinal meninges ) |
|
541 |
D42.9 (Neoplasm of uncertain or unknown behaviour of meninges, unspecified) |
|
542 |
D43.0 (Neoplasm of uncertain or unknown behaviour of brain, supratentorial) |
|
543 |
D43.1 (Neoplasm of uncertain or unknown behaviour of brain, infratentorial) |
|
544 |
D43.2 (Neoplasm of uncertain or unknown behaviour of brain, unspecified) |
|
545 |
D43.3 (Neoplasm of uncertain or unknown behaviour of cranial nerves) |
|
546 |
D43.4 (Neoplasm of uncertain or unknown behaviour of spinal cord) |
|
547 |
D43.7 (Neoplasm of uncertain or unknown behaviour of other parts of central nervous system) |
|
548 |
D43.9 (Neoplasm of uncertain or unknown behaviour of central nervous system, unspecified) |
|
549 |
D44.3 (Neoplasm of uncertain or unknown behaviour of pituitary gland) |
|
550 |
D44.4 (Neoplasm of uncertain or unknown behaviour of craniopharyngeal duct) |
|
551 |
D44.5 (Neoplasm of uncertain or unknown behaviour of pineal gland) |
|
552 |
D45 (Polycythaemia vera) |
|
553 |
D46.0 (Refractory anaemia without ring sideroblasts, so stated) |
|
554 |
D46.1 (Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia) |
|
555 |
D46.2 (Myelodysplastic syndrome with excess blasts) |
|
556 |
D46.3 (Refractory anaemia with excess of blasts with transformation) |
|
557 |
D46.4 (Myelodysplastic syndrome with single lineage dysplasia) |
|
558 |
D46.5 (Myelodysplastic syndrome with multilineage dysplasia) |
|
559 |
D46.6 (Myelodysplastic syndrome with isolated del (5q)) |
|
560 |
D46.7 (Other myelodysplastic syndromes) |
|
561 |
D46.9 (Myelodysplastic syndrome, unspecified) |
|
562 |
D47.1 (Chronic myeloproliferative disease) |
|
563 |
D47.3 (Essential (haemorrhagic) thrombocythaemia) |
|
564 |
D47.4 (Osteomyelofibrosis ) |
|
565 |
D47.5 (Chronic eosinophilic leukaemia [hypereosinophilic syndrome]) |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
ALK |
|
2 |
EGFR |
|
3 |
PD-L1 |
|
4 |
ROS1 |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Positive |
|
2 |
Negative |
|
3 |
Equivocal |
|
4 |
Indeterminate |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Positive |
|
2 |
Negative |
|
3 |
Equivocal |
|
4 |
Indeterminate |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Positive |
|
2 |
Negative |
|
3 |
Equivocal |
|
4 |
Indeterminate |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Positive |
|
2 |
Negative |
|
3 |
Equivocal |
|
4 |
Indeterminate |
|
Imaging Lookups
▼
Lookup Values: This section shows the dropdown, radio button, and checkbox options available for fields in this instrument.
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Chest |
|
2 |
Brain | |
3 |
Abdomen/Pelvis |
|
4 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
CT |
|
2 |
PET |
|
3 |
MRI |
|
4 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Chest |
|
2 |
Brain |
|
3 |
Abdomen/Pelvis |
|
4 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
CT |
|
2 |
PET |
|
3 |
MRI |
|
4 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Chest |
|
2 |
Brain |
|
3 |
Abdomen/Pelvis |
|
4 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
CT |
|
2 |
PET |
|
3 |
MRI |
|
4 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Chest |
|
2 |
Brain |
|
3 |
Abdomen/Pelvis |
|
4 |
Other |
|
MDT Lookups
▼
Lookup Values: This section shows the dropdown, radio button, and checkbox options available for fields in this instrument.
| Code | Label | CQI Numbers |
|---|---|---|
0 |
0 (Fully active) |
|
1 |
1 (Ambulatory - capable of light work) |
|
2 |
2 (Bed < 50% - self caring - not working) |
|
3 |
3 (Bed > 50% - partially self-caring) |
|
4 |
4 (Confined to bed or chair) |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Never |
|
2 |
Past |
|
3 |
Current |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Cerebrovascular disease |
|
2 |
Chronic obstructive pulmonary disease |
|
3 |
Chronic renal failure |
|
4 |
Congestive heart failure |
|
5 |
Connective tissue disease |
|
6 |
Dementia |
|
7 |
Diabetes |
|
8 |
Diabetes with chronic complication |
|
9 |
Hemiplegia/paraplegia |
|
10 |
Human immunodeficiency virus |
|
11 |
Interstitial lung disease |
|
12 |
Leukaemia |
|
13 |
Liver disease - mild |
|
14 |
Liver disease - moderate/severe |
|
15 |
Lymphoma/Multiple myeloma |
|
16 |
Myocardial infarction |
|
17 |
Peripheral vascular disease |
|
18 |
Ulcers - Gastric/Peptic |
|
19 |
2nd malignancy (metastatic) |
|
20 |
2nd malignancy (non-metastatic) |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
T0 |
|
2 |
Tis |
|
3 |
T1mi |
|
4 |
T1a |
|
5 |
T1b |
|
6 |
T1c |
|
7 |
T2a |
|
8 |
T2b |
|
9 |
T3 |
|
10 |
T4 |
|
11 |
TX |
|
12 |
T1 |
|
13 |
T1a1 |
|
14 |
T1a2 |
|
15 |
T1b1 |
|
16 |
T1b2 |
|
26 |
T1b3 |
|
17 |
T2 |
|
18 |
T2a1 |
|
19 |
T2a2 |
|
20 |
T3a |
|
21 |
T3b |
|
22 |
T4a |
|
23 |
T4b |
|
24 |
T4c |
|
25 |
T4d |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
T0 |
|
2 |
Tis |
|
3 |
T1mi |
|
4 |
T1a |
|
5 |
T1b |
|
6 |
T1c |
|
7 |
T2a |
|
8 |
T2b |
|
9 |
T3 |
|
10 |
T4 |
|
11 |
TX |
|
12 |
T1 |
|
13 |
T1a1 |
|
14 |
T1a2 |
|
15 |
T1b1 |
|
16 |
T1b2 |
|
17 |
T2 |
|
18 |
T2a1 |
|
19 |
T2a2 |
|
20 |
T3a |
|
21 |
T3b |
|
22 |
T4a |
|
23 |
T4b |
|
24 |
T4c |
|
25 |
T4d |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
N0 |
|
2 |
N1 |
|
3 |
N2 |
|
4 |
N3 |
|
5 |
NX |
|
6 |
N0a |
|
7 |
N0b |
|
8 |
N1a |
|
9 |
N1b |
|
10 |
N1c |
|
11 |
N2a |
|
12 |
N2b |
|
13 |
N2c |
|
14 |
N3a |
|
15 |
N3b |
|
16 |
N3c |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
N0 |
|
2 |
N1 |
|
3 |
N2 |
|
4 |
N3 |
|
5 |
NX |
|
6 |
N0a |
|
7 |
N0b |
|
8 |
N1a |
|
9 |
N1b |
|
10 |
N1c |
|
11 |
N2a |
|
12 |
N2b |
|
13 |
N2c |
|
14 |
N3a |
|
15 |
N3b |
|
16 |
N3c |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
M0 |
|
2 |
M1a |
|
3 |
M1b |
|
4 |
M1c |
|
5 |
MX |
|
6 |
M1 |
|
7 |
M1c1 |
|
8 |
M1c2 |
|
9 |
M1d |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
M0 |
|
2 |
M1a |
|
3 |
M1b |
|
4 |
M1c |
|
5 |
MX |
|
6 |
M1 |
|
7 |
M1c1 |
|
8 |
M1c2 |
|
9 |
M1d |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
I |
|
2 |
II |
|
3 |
III |
|
4 |
IV |
|
0 |
0 |
|
5 |
IA |
|
6 |
IA1 |
|
7 |
IA2 |
|
8 |
IA3 |
|
9 |
IB |
|
10 |
IC |
|
11 |
IIA |
|
12 |
IIB |
|
13 |
IIC |
|
14 |
IIIA |
|
15 |
IIIB |
|
16 |
IIIC |
|
17 |
IIIC1 |
|
18 |
IIIC2 |
|
19 |
IVA |
|
20 |
IVB |
|
21 |
IVC |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
IA1 |
|
2 |
IA2 |
|
3 |
IA3 |
|
4 |
IB |
|
5 |
IIA |
|
6 |
IIB |
|
7 |
IIIA |
|
8 |
IIIB |
|
9 |
IIIC |
|
10 |
IVA |
|
11 |
IVB |
|
12 |
IA |
|
0 |
0 |
|
13 |
I |
|
14 |
IC |
|
15 |
II |
|
16 |
IIC |
|
17 |
III |
|
18 |
IIIC1 |
|
19 |
IIIC2 |
|
20 |
IV |
|
21 |
IVC |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
IA1 |
|
2 |
IA2 |
|
3 |
IA3 |
|
4 |
IB |
|
5 |
IIA |
|
6 |
IIB |
|
7 |
IIIA |
|
8 |
IIIB |
|
9 |
IIIC |
|
10 |
IVA |
|
11 |
IVB |
|
12 |
IA |
|
0 |
0 |
|
13 |
I |
|
14 |
IC |
|
15 |
II |
|
16 |
IIC |
|
17 |
III |
|
18 |
IIIC1 |
|
19 |
IIIC2 |
|
20 |
IV |
|
21 |
IVC |
|
| Code | Label | CQI Numbers |
|---|---|---|
5 |
10th |
|
1 |
9th |
|
2 |
8th |
|
3 |
7th |
|
4 |
6th |
|
| Code | Label | CQI Numbers |
|---|---|---|
5 |
10th |
|
1 |
9th |
|
2 |
8th |
|
3 |
7th |
|
4 |
6th |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Yes |
|
2 |
No |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
1 |
|
2 |
2 |
|
3 |
3 |
|
4 |
4 |
|
5 |
5 |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Surgery |
|
2 |
Radiation therapy (RT), including palliative RT |
|
3 |
Systemic anti-cancer therapy (SACT) |
|
4 |
SACT + RT |
|
5 |
Surgery + SACT + RT |
|
6 |
Best supportive care |
|
7 |
Further investigations |
|
8 |
Neoadjuvant therapy |
|
9 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Surgery |
|
2 |
Radiation therapy (RT), including palliative RT |
|
3 |
Systemic anti-cancer therapy (SACT) |
|
4 |
SACT + RT |
|
5 |
Surgery + SACT + RT |
|
6 |
Best supportive care |
|
7 |
Further investigations |
|
8 |
Neoadjuvant therapy |
|
9 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Surgery |
|
2 |
Radiation therapy (RT), including palliative RT |
|
3 |
Systemic anti-cancer therapy (SACT) |
|
4 |
SACT + RT |
|
5 |
Surgery + SACT + RT |
|
6 |
Best supportive care |
|
7 |
Further investigations |
|
8 |
Neoadjuvant therapy |
|
9 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Surgery |
|
2 |
Radiation therapy (RT), including palliative RT |
|
3 |
Systemic anti-cancer therapy (SACT) |
|
4 |
SACT + RT |
|
5 |
Surgery + SACT + RT |
|
6 |
Best supportive care |
|
7 |
Further investigations |
|
8 |
Neoadjuvant therapy |
|
9 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Surgery |
|
2 |
Radiation therapy (RT), including palliative RT |
|
3 |
Systemic anti-cancer therapy (SACT) |
|
4 |
SACT + RT |
|
5 |
Surgery + SACT + RT |
|
6 |
Best supportive care |
|
7 |
Further investigations |
|
8 |
Neoadjuvant therapy |
|
9 |
Other |
|
Treatment Lookups
▼
Lookup Values: This section shows the dropdown, radio button, and checkbox options available for fields in this instrument.
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Yes |
|
2 |
No |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Stereotactic (e.g. SBRT, SABR) |
|
2 |
Conventional (e.g. VMAT, IMRT, EBRT) |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Neoadjuvant |
|
2 |
Adjuvant |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Resection - wedge |
|
2 |
Resection - segmental |
|
3 |
Trisegmentectomy |
|
4 |
Lobectomy of lung |
|
5 |
Pneumonectomy |
|
6 |
Other |
|
| Code | Label | CQI Numbers |
|---|---|---|
1 |
Afatinib |
|
2 |
Alectinib |
|
3 |
Atezolizumab |
|
4 |
Capmatinib |
|
5 |
Carboplatin |
|
6 |
Cemiplimab |
|
7 |
Cisplatin |
|
8 |
Clinical_trl |
|
9 |
Cyclophosphamide |
|
10 |
Docetaxel |
|
11 |
Doxorubicin |
|
12 |
Durvalumab |
|
13 |
Entrectinib |
|
14 |
Etoposide |
|
15 |
Gemcitabine |
|
16 |
Irinotecan |
|
17 |
Ipilimumab |
|
18 |
Lorlatinib |
|
19 |
Nivolumab |
|
20 |
Osimertinib |
|
22 |
Paclitaxel |
|
23 |
Pembrolizumab |
|
24 |
Pemetrexed |
|
25 |
Tepotinib |
|
26 |
Topotecan |
|
27 |
Vincristine |
|
28 |
Vinorelbine |
|
99 |
Other |
|
CQI
▼
About CQI: Clinical Quality Indicators (CQI) are measures used to assess and improve the quality of clinical care.
This section provides information about CQIs and their relationship to REDCap fields.
CQI Mapping
▼
CQI to REDCap Field Mapping: This table lists all CQIs and the REDCap fields associated with each indicator. Click on a field name to navigate to its definition in the REDCap Fields section.
CQI Definition
▼
CQI Definitions: This section provides detailed definitions and descriptions for each Clinical Quality Indicator.
| CQI Number | Title | Description |
|---|---|---|
| CQI 1 | Time to first specialist review | Percentage of patients where the time from initial referral to first specialist appointment is ≤14 days. |
| CQI 2 | Time to first diagnostic procedure | Percentage of patients where time from initial referral to first diagnostic procedure is ≤28 days. |
| CQI 3 | Time to first treatment | Percentage of patients diagnosed with lung cancer, where time from initial referral to first anti-cancer treatment is ≤42 days. |
| CQI 4 | Pathological confirmation | Percentage of patients with pathological confirmation of thoracic cancer. |
| CQI 5 | Mesothelioma histological subtypes | Percentage of patients diagnosed with mesothelioma who have complete histological subtype documented. |
| CQI 6 | Biomarker testing | Percentage of patients with Stage IV NSCLC with results available from guideline-concordant biomarker testing. |
| CQI 7 | Invasive mediastinal staging | Percentage of patients with Stage IB-III NSCLC who undergo invasive mediastinal lymph node staging prior to curative-intent treatment. |
| CQI 8 | PET/CT prior to curative-intent treatment | Percentage of patients with lung cancer, with a PET/CT performed within 6 weeks prior to commencing curative-intent treatment. |
| CQI 9 | Brain imaging | Percentage of patients with SCLC (any stage) who have brain imaging performed prior to anti-cancer treatment. |
| CQI 10 | Pulmonary function tests | Percentage of patients with Stage I-III NSCLC who have pulmonary function tests prior to curative-intent treatment. |
| CQI 11 | Multidisciplinary team presentation | Percentage of patients with documented presentation at MDT prior to starting treatment, including an MDT treatment recommendation. |
| CQI 12 | Performance status | Percentage of patients with documented performance status at the time of MDT discussion. |
| CQI 13 | Clinical stage | Percentage of patients with documented clinical stage (cTNM), at time of MDT discussion and treatment recommendation. |
| CQI 14 | Pathological stage | Percentage of patients who underwent surgical resection and had documented pathological stage (pTNM). |
| CQI 15 | Smoking status | Percentage of patients with documented smoking status at the time of diagnosis. |
| CQI 16 | Anti-cancer treatment | Percentage of patients with lung cancer who received any anti-cancer treatment. |
| CQI 17 | Surgical resection in Stage I-II NSCLC | Percentage of patients with Stage I-II NSCLC who underwent surgical resection. |
| CQI 18 | Adequacy of mediastinal lymph node sampling | Percentage of patients with Stage I-II NSCLC who underwent curative-intent surgical resection and had complete mediastinal lymph node dissection or adequate sampling. |
| CQI 19 | Curative-intent treatment in Stage I-II NSCLC | Percentage of patients with Stage I-II NSCLC who underwent curative-intent surgical resection or radiotherapy. |
| CQI 20 | Neoadjuvant and adjuvant therapy in resected NSCLC | Percentage of patients with resected Stage IIA-IIIA NSCLC who received neoadjuvant or adjuvant systemic therapy. |
| CQI 21 | Chemoradiation in Stage III NSCLC | Percentage of patients with Stage III NSCLC and ECOG PS 0-2, who do not undergo surgery, who received concurrent chemoradiation. |
| CQI 22 | Systemic therapy in Stage IV NSCLC | Percentage of patients with Stage IV NSCLC who received any systemic therapy. |
| CQI 23 | Systemic therapy in SCLC | Percentage of patients with SCLC (any stage) who received systemic therapy. |
| CQI 24 | Chemoradiation in Stage I-III SCLC | Percentage of patients with Stage I-III SCLC and ECOG PS 0-2 who received chemoradiation. |
| CQI 25 | Specialist lung cancer nurse review | Percentage of patients seen by a specialist lung cancer nurse around the time of diagnosis. |
| CQI 26 | Death following curative-intent treatment | Percentage of patients who die within 30 days of any curative-intent treatment. |
| CQI 27 | Systemic therapy at the end of life | Percentage of patients who receive systemic therapy within 30 days prior to death. |